Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by Bdigginson Mar 20, 2018 11:11am
142 Views
Post# 27746402

RE:RE:RE:yes 4050 as potential be be great drug but they

RE:RE:RE:yes 4050 as potential be be great drug but theyThat’s a lot of questions ,,,, 
i think I gave  expectation on a previous post ....
1.70-2.00 on fda maybe higher depending on where the sp sits on release... could push up  into the 2.30 range on volume 
tne voutucher could be worth around 300 million ( a little high ) 
last one sold around 285 m  figure that in ... 50 cents ( guess) 
delays well 1.12 is the low resistance 

Good enough ?



Bullboard Posts